2024 Q2 Form 10-Q Financial Statement

#000106163024000064 Filed on April 24, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $466.2M $486.1M
YoY Change -10.68% -1.07%
Cost Of Revenue $358.1M $362.7M
YoY Change -5.1% 4.14%
Gross Profit $108.0M $123.5M
YoY Change -25.24% -13.74%
Gross Profit Margin 23.18% 25.4%
Selling, General & Admin $13.66M $12.25M
YoY Change 24.68% 12.05%
% of Gross Profit 12.64% 9.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $185.0K
YoY Change
% of Gross Profit 0.17%
Operating Expenses $13.66M $248.6M
YoY Change 4.9% 1832.34%
Operating Profit $94.39M -$125.1M
YoY Change -28.23% -196.05%
Interest Expense $343.7M
YoY Change 8.36%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$58.99M -$122.2M
YoY Change -156.88% -201.43%
Income Tax $1.200M $1.002M
% Of Pretax Income
Net Earnings -$61.06M -$123.8M
YoY Change -160.07% -205.16%
Net Earnings / Revenue -13.1% -25.47%
Basic Earnings Per Share -$0.35 -$0.71
Diluted Earnings Per Share -$0.35 -$0.71
COMMON SHARES
Basic Shares Outstanding 173.6M shares 173.7M shares
Diluted Shares Outstanding 174.0M shares 174.0M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $373.9M $414.0M
YoY Change -22.57% -19.74%
Cash & Equivalents $373.9M $414.0M
Short-Term Investments
Other Short-Term Assets $650.0K $115.5M
YoY Change -98.69% 15.69%
Inventory
Prepaid Expenses
Receivables $196.8M $206.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $373.9M $735.7M
YoY Change -48.17% -7.76%
LONG-TERM ASSETS
Property, Plant & Equipment $60.02M $60.20M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $22.26B $22.53B
YoY Change -7.78% -8.37%
TOTAL ASSETS
Total Short-Term Assets $373.9M $735.7M
Total Long-Term Assets $22.26B $22.53B
Total Assets $22.64B $23.27B
YoY Change -8.95% -8.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.365M $6.839M
YoY Change -26.98% -20.37%
Accrued Expenses $108.9M $105.6M
YoY Change 3.36% 11.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $223.0M $220.1M
YoY Change -6.02% -2.7%
LONG-TERM LIABILITIES
Long-Term Debt $18.37B $18.84B
YoY Change -8.14% -8.27%
Other Long-Term Liabilities $257.3M $37.87M
YoY Change 353.17% -33.61%
Total Long-Term Liabilities $18.63B $18.88B
YoY Change -7.12% -8.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $223.0M $220.1M
Total Long-Term Liabilities $18.63B $18.88B
Total Liabilities $18.63B $19.12B
YoY Change -8.32% -8.18%
SHAREHOLDERS EQUITY
Retained Earnings -$1.552B -$1.383B
YoY Change 61.05% 44.32%
Common Stock $5.526B $5.518B
YoY Change 0.59% 0.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.985B $4.145B
YoY Change
Total Liabilities & Shareholders Equity $22.64B $23.27B
YoY Change -8.95% -8.35%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$61.06M -$123.8M
YoY Change -160.07% -205.16%
Depreciation, Depletion And Amortization $185.0K
YoY Change
Cash From Operating Activities $100.2M $94.61M
YoY Change -21.67% -14.13%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $488.1M $376.3M
YoY Change -16.16% 140.41%
Cash From Investing Activities $488.1M $376.3M
YoY Change -16.16% 140.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -628.4M -404.3M
YoY Change -15.62% 824.74%
NET CHANGE
Cash From Operating Activities 100.2M 94.61M
Cash From Investing Activities 488.1M 376.3M
Cash From Financing Activities -628.4M -404.3M
Net Change In Cash -40.20M 66.58M
YoY Change 15.69% -70.14%
FREE CASH FLOW
Cash From Operating Activities $100.2M $94.61M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
486122000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
491384000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
343730000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
317197000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-123170000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
118556000 usd
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173582305 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
173582305 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
118556000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4164587000 usd
CY2023Q1 us-gaap Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration
OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#InterestExpense
CY2024Q1 us-gaap Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration
OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#InterestExpense
CY2024Q1 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
12387289000 usd
CY2023Q4 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
12683095000 usd
CY2024Q1 bxmt Securitized Debt Obligations Net
SecuritizedDebtObligationsNet
2328073000 usd
CY2023Q4 bxmt Securitized Debt Obligations Net
SecuritizedDebtObligationsNet
2505417000 usd
CY2024Q1 bxmt Asset Specific Debt Agreements Net
AssetSpecificDebtAgreementsNet
1061380000 usd
CY2023Q4 bxmt Asset Specific Debt Agreements Net
AssetSpecificDebtAgreementsNet
1000210000 usd
CY2024Q1 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
334909000 usd
CY2023Q4 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
337179000 usd
CY2024Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
2098415000 usd
CY2023Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
2101632000 usd
CY2024Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
296166000 usd
CY2023Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
295847000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
142392000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
174187000 usd
CY2024Q1 us-gaap Management Fee Expense
ManagementFeeExpense
18927000 usd
CY2023Q1 us-gaap Management Fee Expense
ManagementFeeExpense
31050000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13728000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12865000 usd
CY2024Q1 us-gaap Noninterest Expense
NoninterestExpense
32655000 usd
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
43915000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
234868000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
9823000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2963000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-122168000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
120449000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1002000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1893000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-123170000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
118556000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
668000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
799000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-123838000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
117757000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174041630 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172598349 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
174041630 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180869409 shares
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-45732000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
21858000 usd
CY2024Q1 bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
46148000 usd
CY2023Q1 bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-24052000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
416000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2194000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-122754000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
116362000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
668000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
799000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-123422000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
115563000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4544200000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
7492000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
287000 usd
CY2023Q1 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
163000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2194000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2023Q1 us-gaap Dividends
Dividends
107072000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
733000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4560699000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4387504000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
7911000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
253000 usd
CY2024Q1 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
201000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-123170000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
416000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2024Q1 us-gaap Dividends
Dividends
107901000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
627000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-123170000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
118556000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8112000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7655000 usd
CY2024Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
16433000 usd
CY2023Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
21755000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10550000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
14811000 usd
CY2024Q1 bxmt Payment In Kind Interest Net Of Interest Received
PaymentInKindInterestNetOfInterestReceived
2329000 usd
CY2023Q1 bxmt Payment In Kind Interest Net Of Interest Received
PaymentInKindInterestNetOfInterestReceived
556000 usd
CY2024Q1 bxmt Increase Decrease In Current Expected Credit Loss Reserve
IncreaseDecreaseInCurrentExpectedCreditLossReserve
234868000 usd
CY2023Q1 bxmt Increase Decrease In Current Expected Credit Loss Reserve
IncreaseDecreaseInCurrentExpectedCreditLossReserve
9823000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2963000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-482000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-541000 usd
CY2024Q1 bxmt Realized Gains Losses On Derivative Financial Instruments Net
RealizedGainsLossesOnDerivativeFinancialInstrumentsNet
4895000 usd
CY2023Q1 bxmt Realized Gains Losses On Derivative Financial Instruments Net
RealizedGainsLossesOnDerivativeFinancialInstrumentsNet
8948000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-8334000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-10422000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-17946000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-20932000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
94610000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
109617000 usd
CY2024Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
301678000 usd
CY2023Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
369256000 usd
CY2024Q1 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
637242000 usd
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
562072000 usd
CY2024Q1 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
4550000 usd
CY2023Q1 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
2850000 usd
CY2024Q1 bxmt Payments For Derivative Instruments In Investing Activities
PaymentsForDerivativeInstrumentsInInvestingActivities
72113000 usd
CY2023Q1 bxmt Payments For Derivative Instruments In Investing Activities
PaymentsForDerivativeInstrumentsInInvestingActivities
136689000 usd
CY2024Q1 bxmt Proceeds From Derivative Instruments In Investing Activities
ProceedsFromDerivativeInstrumentsInInvestingActivities
4815000 usd
CY2023Q1 bxmt Proceeds From Derivative Instruments In Investing Activities
ProceedsFromDerivativeInstrumentsInInvestingActivities
5370000 usd
CY2024Q1 bxmt Payments For Collateral Deposits Related To Derivatives
PaymentsForCollateralDepositsRelatedToDerivatives
16990000 usd
CY2023Q1 bxmt Payments For Collateral Deposits Related To Derivatives
PaymentsForCollateralDepositsRelatedToDerivatives
79970000 usd
CY2024Q1 bxmt Proceeds From Collateral Deposits Related To Derivatives
ProceedsFromCollateralDepositsRelatedToDerivatives
120490000 usd
CY2023Q1 bxmt Proceeds From Collateral Deposits Related To Derivatives
ProceedsFromCollateralDepositsRelatedToDerivatives
172710000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
376316000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
157087000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
529753000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
947245000 usd
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
671610000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
521407000 usd
CY2024Q1 bxmt Repayments For Collateralized Loan Obligations
RepaymentsForCollateralizedLoanObligations
178058000 usd
CY2023Q1 bxmt Repayments For Collateralized Loan Obligations
RepaymentsForCollateralizedLoanObligations
1807000 usd
CY2024Q1 bxmt Proceeds From Asset Specific Debt Agreements
ProceedsFromAssetSpecificDebtAgreements
60387000 usd
CY2023Q1 bxmt Proceeds From Asset Specific Debt Agreements
ProceedsFromAssetSpecificDebtAgreements
78496000 usd
CY2024Q1 bxmt Repayments Of Asset Specific Debt Agreements
RepaymentsOfAssetSpecificDebtAgreements
0 usd
CY2023Q1 bxmt Repayments Of Asset Specific Debt Agreements
RepaymentsOfAssetSpecificDebtAgreements
206300000 usd
CY2024Q1 bxmt Repayments Of Secured Term Loans
RepaymentsOfSecuredTermLoans
5499000 usd
CY2023Q1 bxmt Repayments Of Secured Term Loans
RepaymentsOfSecuredTermLoans
5499000 usd
CY2024Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
22984000 usd
CY2023Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 usd
CY2024Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2023Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
220000000 usd
CY2024Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
8315000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7265000 usd
CY2024Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
627000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
733000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
107390000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
106455000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-404343000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43725000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
66583000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
222979000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
350014000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
291340000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2611000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1489000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
413986000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
515808000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
343609000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
318185000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1161000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
900000 usd
CY2024Q1 bxmt Dividends Declared And Not Paid
DividendsDeclaredAndNotPaid
107678000 usd
CY2023Q1 bxmt Dividends Declared And Not Paid
DividendsDeclaredAndNotPaid
106816000 usd
CY2024Q1 bxmt Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
90006000 usd
CY2023Q1 bxmt Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
19756000 usd
CY2024Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
60203000 usd
CY2023Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
0 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
ORGANIZATION <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">References herein to “Blackstone Mortgage Trust,” “Company,” “we,” “us” or “our” refer to Blackstone Mortgage Trust, Inc., a Maryland corporation, and its subsidiaries unless the context specifically requires otherwise. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Blackstone Mortgage Trust is a real estate finance company that originates senior loans collateralized by commercial real estate in North America, Europe, and Australia. Our portfolio is composed primarily of loans secured by high-quality, institutional assets in major markets, sponsored by experienced, well-capitalized real estate investment owners and operators. These senior loans are capitalized by accessing a variety of financing options, including borrowing under our credit facilities, issuing CLOs or single-asset securitizations, and corporate financing, depending on our view of the most prudent financing option available for each of our investments. We are not in the business of buying or trading securities, and the only securities we own are the retained interests from our securitization financing transactions, which we have not financed. We are externally managed by BXMT Advisors L.L.C., or our Manager, a subsidiary of Blackstone Inc., or Blackstone, and are a real estate investment trust, or REIT, traded on the New York Stock Exchange, or NYSE, under the symbol “BXMT.” Our principal executive offices are located at 345 Park Avenue, 24th Floor, New York, New York 10154. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We conduct our operations as a REIT for U.S. federal income tax purposes. We generally will not be subject to U.S. federal income taxes on our taxable income to the extent that we annually distribute all of our net taxable income to stockholders and maintain our qualification as a REIT. We also operate our business in a manner that permits us to maintain an exclusion from registration under the Investment Company Act of 1940, as amended. We are organized as a holding company and conduct our business primarily through our various subsidiaries.</span></div>
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain reclassifications have been made in the presentation of the prior period statement of cash flows related to payment-in-kind interest and principal fundings of loans receivable and in new financings by spread in Note 6 to conform to the current period presentation.
CY2017Q4 bxmt Joint Venture Capital Contribution Percentage
JointVentureCapitalContributionPercentage
0.85
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Estimates </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may ultimately differ materially from those estimates.</span></div>
CY2024Q1 us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenue Recognition </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest income from our loans receivable portfolio is recognized over the life of each investment using the effective interest method and is recorded on the accrual basis. Recognition of fees, premiums, and discounts associated with these investments is deferred and recorded over the term of the loan as an adjustment to yield. Income accrual is generally suspended for loans at the earlier of the date at which payments become 90 days past due or when, in our opinion, recovery of income and principal becomes doubtful. Interest received is then recorded as income or as a reduction in the amortized cost basis, based on the specific facts and circumstances, until accrual is resumed when the loan becomes contractually current and performance is demonstrated to be resumed. In addition, for loans we originate, the related origination expenses are deferred and recognized as a reduction to interest income, however expenses related to loans we acquire are included in general and administrative expenses as incurred.</span></div>
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2024Q1 us-gaap Escrow Deposit
EscrowDeposit
582300000 usd
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
640600000 usd
CY2024Q1 bxmt Real Estate Owned Number Of Assets Classified As Held For Sale
RealEstateOwnedNumberOfAssetsClassifiedAsHeldForSale
1 real_estate_owned_asset
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
751370000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
22437942000 usd
CY2024Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
173 loan
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23189312000 usd
CY2024Q1 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
23959967000 usd
CY2024Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
173 security_loan
CY2023 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
178 security_loan
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23317882000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23923719000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
22437942000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23210076000 usd
CY2024Q1 bxmt Mortgage Loan On Real Estate Final Maturity Term
MortgageLoanOnRealEstateFinalMaturityTerm
P2Y2M12D
CY2023 bxmt Mortgage Loan On Real Estate Final Maturity Term
MortgageLoanOnRealEstateFinalMaturityTerm
P2Y4M24D
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23317882000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23923719000 usd
CY2023Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-136707000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23787012000 usd
CY2024Q1 bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
301678000 usd
CY2024Q1 bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
301678000 usd
CY2024Q1 bxmt Financing Receivable Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
582248000 usd
CY2024Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
16818000 usd
CY2024Q1 bxmt Financing Receivable Before Allowance For Credit Loss Fee And Loan In Process Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableBeforeAllowanceForCreditLossFeeAndLoanInProcessSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
599066000 usd
CY2024Q1 bxmt Financing Receivable Writeoff
FinancingReceivableWriteoff
73176000 usd
CY2024Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Writeoff
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountWriteoff
12163000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
61013000 usd
CY2024Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
60203000 usd
CY2024Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
60203000 usd
CY2024Q1 bxmt Financing Receivable Transfer To Other Assets
FinancingReceivableTransferToOtherAssets
8800000 usd
CY2024Q1 bxmt Financing Receivable Transfer To Other Assets
FinancingReceivableTransferToOtherAssets
8800000 usd
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
2329000 usd
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
2329000 usd
CY2024Q1 bxmt Financing Receivable Gain Loss On Foreign Currency Translation
FinancingReceivableGainLossOnForeignCurrencyTranslation
-185417000 usd
CY2024Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Gain Loss On Foreign Currency Translation
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountGainLossOnForeignCurrencyTranslation
-909000 usd
CY2024Q1 bxmt Financing Receivable Before Allowance For Credit Loss Fee And Loan In Process Gain Loss On Foreign Currency Translation
FinancingReceivableBeforeAllowanceForCreditLossFeeAndLoanInProcessGainLossOnForeignCurrencyTranslation
-184508000 usd
CY2024Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
4550000 usd
CY2024Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
4550000 usd
CY2024Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
16433000 usd
CY2024Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
16433000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23317882000 usd
CY2024Q1 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-128570000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23189312000 usd
CY2024Q1 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
21108868000 usd
CY2024Q1 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
751370000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
22437942000 usd
CY2024Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
173 loan
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23189312000 usd
CY2024Q1 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
23959967000 usd
CY2024Q1 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
21108868000 usd
CY2024Q1 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
751370000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
22437942000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23300000000 usd
CY2024Q1 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
742600000 usd
CY2024Q1 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
742600000 usd
CY2024Q1 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
1100000000 usd
CY2024Q1 bxmt Financing Receivable Aggregate Unamortized Loan Fee Cost And Purchase Premium Discount Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableAggregateUnamortizedLoanFeeCostAndPurchasePremiumDiscountSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
57900000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
751400000 usd
CY2023 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
178 loan
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23787012000 usd
CY2023Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
24971028000 usd
CY2023Q4 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
21951988000 usd
CY2023Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576936000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23210076000 usd
CY2023Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
24971028000 usd
CY2023Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2023Q4 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
1000000000 usd
CY2023Q4 bxmt Financing Receivable Aggregate Unamortized Loan Fee Cost And Purchase Premium Discount Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableAggregateUnamortizedLoanFeeCostAndPurchasePremiumDiscountSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
53000000.0 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576900000 usd
CY2024Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
173 loan
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23189312000 usd
CY2024Q1 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
23959967000 usd
CY2024Q1 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
21108868000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
751370000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
22437942000 usd
CY2023 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
178 loan
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23787012000 usd
CY2023Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
24971028000 usd
CY2023Q4 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
21951988000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576936000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23210076000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23300000000 usd
CY2024Q1 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
742600000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23900000000 usd
CY2023Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1100000000 usd
CY2024Q1 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
742600000 usd
CY2024Q1 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
1100000000 usd
CY2024Q1 bxmt Financing Receivable Aggregate Unamortized Loan Fee Cost And Purchase Premium Discount Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableAggregateUnamortizedLoanFeeCostAndPurchasePremiumDiscountSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
57900000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
751400000 usd
CY2023Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1100000000 usd
CY2023Q4 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
1000000000 usd
CY2023Q4 bxmt Financing Receivable Aggregate Unamortized Loan Fee Cost And Purchase Premium Discount Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableAggregateUnamortizedLoanFeeCostAndPurchasePremiumDiscountSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
53000000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576900000 usd
CY2023Q4 bxmt Weighted Average Risk Rating
WeightedAverageRiskRating
3.0
CY2024Q1 bxmt Weighted Average Risk Rating
WeightedAverageRiskRating
3.0
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576936000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
235447000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
61013000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
751370000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
10454000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
336591000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
235400000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
751400000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
751370000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
22437942000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff
0 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
0 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff
0 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff
54313000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff
0 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff
6700000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
61013000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576936000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23210076000 usd
CY2024 bxmt Financing Receivable Modified Number Of Contracts
FinancingReceivableModifiedNumberOfContracts
7 loan
CY2024Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
60200000 usd
CY2024Q1 bxmt Land And Site Improvements Acquired Through Foreclosure
LandAndSiteImprovementsAcquiredThroughForeclosure
40824000 usd
CY2024Q1 bxmt Building Acquired Through Foreclosure
BuildingAcquiredThroughForeclosure
19379000 usd
CY2024Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
60203000 usd
CY2024Q1 bxmt Real Estate Owned Liabilities
RealEstateOwnedLiabilities
0 usd
CY2024Q1 bxmt Real Estate Owned Impairment Charges
RealEstateOwnedImpairmentCharges
0 usd
CY2024Q1 bxmt Real Estate Owned Income
RealEstateOwnedIncome
0 usd
CY2024Q1 bxmt Real Estate Owned Expense
RealEstateOwnedExpense
0 usd
CY2023Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
0 usd
CY2023Q4 bxmt Real Estate Owned Liabilities
RealEstateOwnedLiabilities
0 usd
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
206227000 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
214835000 usd
CY2024Q1 bxmt Loan Portfolio Payments Held By Our Third Party Loan Servicer
LoanPortfolioPaymentsHeldByOurThirdPartyLoanServicer
114247000 usd
CY2023Q4 bxmt Loan Portfolio Payments Held By Our Third Party Loan Servicer
LoanPortfolioPaymentsHeldByOurThirdPartyLoanServicer
152423000 usd
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
25922000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
1890000 usd
CY2024Q1 bxmt Accounts Receivable Net Current And Other Assets Current
AccountsReceivableNetCurrentAndOtherAssetsCurrent
6079000 usd
CY2023Q4 bxmt Accounts Receivable Net Current And Other Assets Current
AccountsReceivableNetCurrentAndOtherAssetsCurrent
2420000 usd
CY2024Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1257000 usd
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1020000 usd
CY2024Q1 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
0 usd
CY2023Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
103500000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
353732000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
476088000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
107678000 usd
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
107390000 usd
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
86643000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
97820000 usd
CY2024Q1 bxmt Secured Debt Repayments Pending Servicer Remittance
SecuredDebtRepaymentsPendingServicerRemittance
24240000 usd
CY2023Q4 bxmt Secured Debt Repayments Pending Servicer Remittance
SecuredDebtRepaymentsPendingServicerRemittance
13526000 usd
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
12644000 usd
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
15371000 usd
CY2024Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
6839000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
7265000 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
990000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
94817000 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
257961000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
362531000 usd
CY2024Q1 bxmt Debt Instrument Covenant Requirement On Consolidated Tangible Net Worth Minimum
DebtInstrumentCovenantRequirementOnConsolidatedTangibleNetWorthMinimum
3600000000 usd
CY2024Q1 bxmt Debt Instrument Covenant Maximum Percentage Of Cash Liquidity On Recourse Indebtedness
DebtInstrumentCovenantMaximumPercentageOfCashLiquidityOnRecourseIndebtedness
0.05
CY2024Q1 bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
41500000 usd
CY2023 bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
171400000 usd
CY2024Q1 us-gaap Share Price
SharePrice
19.91
CY2024Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
723000 usd
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
25922000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
1890000 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
990000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
94817000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
46573000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-24052000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
425000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
0 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
343700000 usd
CY2024Q1 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
0 usd
CY2023Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
103500000 usd
CY2024Q1 bxmt Stock Shares Authorized
StockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
173569397 shares
CY2022Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
172106593 shares
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1436 shares
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1377 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
370936 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
481724 shares
CY2024Q1 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
10709 shares
CY2023Q1 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
10903 shares
CY2024Q1 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
173952478 shares
CY2023Q1 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
172600597 shares
CY2024Q1 bxmt Deferred Stock Units
DeferredStockUnits
370173 shares
CY2023Q1 bxmt Deferred Stock Units
DeferredStockUnits
316479 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
1436 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
1377 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2024Q1 us-gaap Dividends
Dividends
107700000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2024Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
223000 usd
CY2023Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
256000 usd
CY2024Q1 us-gaap Dividends
Dividends
107901000 usd
CY2023Q1 us-gaap Dividends
Dividends
107072000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-123838000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
117757000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174041630 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172598349 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-123838000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
117757000 usd
CY2024Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2023Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
3556000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-123838000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
121313000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174041630 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172598349 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
8271060 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
174041630 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180869409 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2024Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9900000 usd
CY2024Q1 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
230000000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-220100000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9500000 usd
CY2023Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
183900000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-174400000 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
4140000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
3279000 usd
CY2024Q1 bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
1476000 usd
CY2023Q1 bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
1931000 usd
CY2024Q1 bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
5616000 usd
CY2023Q1 bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
5210000 usd
CY2024Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
7911000 usd
CY2023Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
7492000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
201000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
163000 usd
CY2024Q1 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
8112000 usd
CY2023Q1 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
7655000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13728000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12865000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000.0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1900000 usd
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
25875000 shares
CY2024Q1 bxmt Operating Loss Carryforwards Limitations On Use Annual Limitation
OperatingLossCarryforwardsLimitationsOnUseAnnualLimitation
2000000.0 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
159000000.0 usd
CY2024Q1 bxmt Number Of Current Benefit Plans
NumberOfCurrentBenefitPlans
2 plan
CY2024Q1 bxmt Number Of Benefit Plans
NumberOfBenefitPlans
9 plan
CY2024Q1 bxmt Number Of Expired Benefit Plans
NumberOfExpiredBenefitPlans
7 plan
CY2024Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
413986000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
350014000 usd
CY2024Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
23317882000 usd
CY2023Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
23923719000 usd
CY2024Q1 bxmt Securitized Debt Obligations Net Face Amount
SecuritizedDebtObligationsNetFaceAmount
2329456000 usd
CY2023Q4 bxmt Securitized Debt Obligations Net Face Amount
SecuritizedDebtObligationsNetFaceAmount
2507514000 usd
CY2024Q1 bxmt Asset Specific Debt Gross
AssetSpecificDebtGross
1064484000 usd
CY2023Q4 bxmt Asset Specific Debt Gross
AssetSpecificDebtGross
1004097000 usd
CY2024Q1 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
335280000 usd
CY2023Q4 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
337721000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2249402000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2531803000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5344883000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3900110000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
532939000 usd
CY2024Q1 bxmt Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1678437000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
16237574000 usd
CY2024Q1 bxmt Debt Instrument Amortization Percentage
DebtInstrumentAmortizationPercentage
0.010
CY2024Q1 bxmt Securitized Debt Obligations Excluded From Contractual Obligations
SecuritizedDebtObligationsExcludedFromContractualObligations
2300000000 usd
CY2024Q1 bxmt Nonconsolidated Securitized Debt Excluded From Contractual Obligations
NonconsolidatedSecuritizedDebtExcludedFromContractualObligations
742600000 usd
CY2024Q1 bxmt Net Loan Exposure Amount Loan Participations Sold
NetLoanExposureAmountLoanParticipationsSold
335300000 usd
CY2024Q1 bxmt Board Of Directors Number Of Members
BoardOfDirectorsNumberOfMembers
9 director
CY2024Q1 bxmt Number Of Non Employee Directors Eligible For Annual Compensation
NumberOfNonEmployeeDirectorsEligibleForAnnualCompensation
7 director
CY2024Q1 bxmt Number Of Directors Not Eligible For Compensation
NumberOfDirectorsNotEligibleForCompensation
2 director
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001061630-24-000064-index-headers.html Edgar Link pending
0001061630-24-000064-index.html Edgar Link pending
0001061630-24-000064.txt Edgar Link pending
0001061630-24-000064-xbrl.zip Edgar Link pending
bxmt-20240331.htm Edgar Link pending
bxmt-20240331.xsd Edgar Link pending
bxmt-20240331_g1.gif Edgar Link pending
bxmt-20240331_g2.jpg Edgar Link pending
bxmt-20240331_g3.jpg Edgar Link pending
exhibit1011q24.htm Edgar Link pending
exhibit3111q24.htm Edgar Link pending
exhibit3121q24.htm Edgar Link pending
exhibit3211q24.htm Edgar Link pending
exhibit3221q24.htm Edgar Link pending
exhibit9911q24.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
bxmt-20240331_def.xml Edgar Link unprocessable
bxmt-20240331_lab.xml Edgar Link unprocessable
bxmt-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bxmt-20240331_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bxmt-20240331_cal.xml Edgar Link unprocessable